Chemotherapy with methotrexate, vinblastine, epirubicin and carboplatin (Carbo-MVE) in transitional cell urothelial cancer. A Hellenic Co-Operative Oncology Group Study

European Urology

Volumn 31, Issue 4, 1997, Pages 420-427

  Skarlos, D V ^a   Aravantinos, G ^a   Linardou, E ^a   Kostakopoulos, C A ^a   Kastriotis, I ^a   Christodoulou, C ^a   Picramenos, D ^a   Giannakakis, Th ^a   Dimopoulos, K ^a   Fountzilas, G ^a  

^a Hellenic Cooperative Oncology Group   (Greece)

Author keywords

Bladder cancer; Carboplatin; Chemotherapy; Transitional cell carcinoma

Indexed keywords

CARBOPLATIN; EPIRUBICIN; METHOTREXATE; VINBLASTINE;

ADULT; AGED; ALOPECIA; ARTICLE; BLADDER CANCER; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CYSTECTOMY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; METASTASIS; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SIDE EFFECT; THROMBOCYTOPENIA; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME; UROGENITAL TRACT TUMOR;

EID: 0030922990     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000474500     Document Type: Article

References (27)